Recent Articles

June 26, 2017 10:45 am
Jae Chung, Founder and President, goBalto
There is no doubt that technology solutions help both sponsors and contract research organizations (CROs) improve operational efficiencies and facilitate decision making. While one would expect to hear a similar story from all stakeholders involved in clinical trials, a recent survey suggests that these technologies are having the opposite effect at investigative sites - adding to what is already a heavy workload burden.
June 21, 2017 10:48 am
University of California, San Francisco
What we don't know could heal — or harm.
June 14, 2017 9:54 am
Joe Clayton, Ph.D., Brad Larson, & Peter Banks, Ph.D., Applications Scientists, BioTek Instruments, Inc.
Kinetic imaging of live cells provides a useful framework in which to gather meaningful details of cellular dynamics in real time, however, applications are often constrained by the limited versatility of available instruments. Here, we describe an automated live cell imager designed for a wide range of temporal dynamics in live cell assays.
May 22, 2017 10:39 am
Ian Haydon, University of Washington
Researchers are starting to harness the potential of this much-hyped gene editing technique – with coming applications in medicine, biology and agriculture.
May 17, 2017 9:34 am
Erin Connelly, University of Pennsylvania
A team of medievalists and scientists look back to history – including a 1,000-year-old eyesalve recipe – for clues to new antibiotics.
May 8, 2017 11:46 am
Bevin Fletcher
Helen Torley, M.B, Ch.B., came across an interesting statistic last year. Out of the 44 publicly traded biotech companies in the thriving life science hub of San Diego, there was only one female CEO: her.
May 4, 2017 9:58 am
Elana Fertig, Johns Hopkins University, The Conversation
Cancer researchers dream of offering personalized treatments to patients. Can they get there using the same math that drives Netflix recommendations?
May 1, 2017 11:01 am
Bevin Fletcher
Simone T. Sredni, M.D., Ph.D., associate professor of pediatric neurosurgery has been working in pediatric brain cancer research for about 15 years. In interview with Bioscience Technology, Sredni said she has “never felt so close” to finding a better treatment for atypical teratoid/rhabdoid tumors (AT/RT) —and the powerful gene-editing tool CRISPR/Cas9 helped her get there.
May 1, 2017 10:52 am
Jan Rowell
From pre-surgery brain scans to genomic-enhanced diagnosis, high-performance computing is beginning to transform the practice of medicine.
Subscribe to Bioscience Technology